Gene · 309
Papers2,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell Surface Engineering Enables Surfaceome Profiling. | ACS Chem Biol | 2023 | 35443134 | PubTator, text mining | PubMed |
| Meeting report of the 2nd Lugano ExoDay: extracellular vesicles as next-generation clinical biomarkers and therapeutic agents. | Extracell Vesicles Circ Nucl Acids | 2022 | 39697493 | PubTator, text mining | PubMed |
| Fluorescence evidence of annexin A6 translocation across membrane in model matrix vesicles during apatite formation. | J Extracell Biol | 2022 | 38939118 | PubTator, text mining | PubMed |
| Low circulatory Fe and Se levels with a higher IL-6/IL-10 ratio provide nutritional immunity in tuberculosis. | Front Immunol | 2022 | 36713405 | PubTator, text mining | PubMed |
| Identification of genes involved in chicken follicle selection by ONT sequencing on granulosa cells. | Front Genet | 2022 | 36712880 | PubTator, text mining | PubMed |
| Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. | World J Gastroenterol | 2022 | 36632312 | PubTator, text mining | PubMed |
| Extracellular Vesicles' Role in the Pathophysiology and as Biomarkers in Cystic Fibrosis and COPD. | Int J Mol Sci | 2022 | 36613669 | PubTator, text mining | PubMed |
| Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 36612209 | PubTator, text mining | PubMed |
| MANF/EWSR1/ANXA6 pathway might as the bridge between hypolipidemia and major depressive disorder. | Transl Psychiatry | 2022 | 36585419 | PubTator, text mining | PubMed |
| Physiological adaptations and myocellular stress in short-term, high-frequency blood flow restriction training: A scoping review. | PLoS One | 2022 | 36584157 | PubTator, text mining | PubMed |
| Interplay of membrane crosslinking and curvature induction by annexins. | Sci Rep | 2022 | 36581673 | PubTator, text mining | PubMed |
| Hepeliviruses in two waterbodies in Berlin, Germany. | Arch Virol | 2022 | 36566475 | PubTator, text mining | PubMed |
| Application of a Human Blood Brain Barrier Organ-on-a-Chip Model to Evaluate Small Molecule Effectiveness against Venezuelan Equine Encephalitis Virus. | Viruses | 2022 | 36560802 | PubTator, text mining | PubMed |
| The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment. | Molecules | 2022 | 36558146 | PubTator, text mining | PubMed |
| Fluid Shear Stress Regulates Osteogenic Differentiation via AnnexinA6-Mediated Autophagy in MC3T3-E1 Cells. | Int J Mol Sci | 2022 | 36555344 | PubTator, text mining | PubMed |
| Is Purchase Behavior Different for Consumers with Long COVID? | Int J Environ Res Public Health | 2022 | 36554538 | PubTator, text mining | PubMed |
| Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells. | Cells | 2022 | 36552728 | PubTator, text mining | PubMed |
| Anastellin impacts on the processing of extracellular matrix fibronectin and stimulates release of cytokines from coronary artery smooth muscle cells. | Sci Rep | 2022 | 36543832 | PubTator, text mining | PubMed |
| The cholesteryl-ester transfer protein isoform (CETPI) and derived peptides: new targets in the study of Gram-negative sepsis. | Mol Med | 2022 | 36536294 | PubTator, text mining | PubMed |
| Tumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance. | Int J Mol Sci | 2022 | 36499561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/309/papers?page=12